Sakao Yukinori, Nakazono Takahiko, Tomimitsu Shinji, Takeda Yuji, Sakuragi Toru, Natsuaki Masafumi, Itoh Tsuyoshi
Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Nabesima 5-1-1, Saga 849-8501, Japan.
Eur J Cardiothorac Surg. 2004 Dec;26(6):1211-5. doi: 10.1016/j.ejcts.2004.08.021.
We sought to verify that the size of the solid component, which can be evaluated using the computed tomography mediastinal-window setting, provides new criteria for CT classification of lung adenocarcinoma.
Between 1994 and September 2002, we examined 60 patients who were clinically classified with stage T1 adenocarcinoma of the lung and normal serum CEA, who underwent standard surgical procedures. Tumor maximum dimension was evaluated using two different CT-imaging settings: the lung window (lDmax), and the mediastinal window (mDmax). We analyzed the relationships between prognosis or lymph node involvement and tumor dimensions.
The mDmax was a significant (OR 1.11, P=0.02) predictive factor for lymph node metastasis. However, lDmax was not significant (P=0.83). Age, gender, lDmax, mDmax, and lymph node involvement were analyzed as predictive factors for prognosis. In univariate analysis, mDmax and lymph node involvement were significant predictive factors for prognosis (OR 1.07, P=0.01; OR 2.56, P=0.04; respectively). In multivariate analysis, mDmax was a significant predictive factor for prognosis (OR 1.06, P=0.04). We then classified the C-T1 adenocarcinoma patients into three groups according to mDmax: T1a (< or =10 mm), T1b (from 11 to 20 mm), and T1c (from 21 to 30 mm). There was a significant difference between the three groups: the disease-free 5-year survivals were 93.3, 58.1, and 32.7%, respectively (P=0.01).
The mDmax can give additional, useful prognostic data. This finding may provide new criteria for CT classification of lung adenocarcinoma.
我们试图验证通过计算机断层扫描纵隔窗设置评估的实性成分大小能否为肺腺癌的CT分类提供新的标准。
在1994年至2002年9月期间,我们检查了60例临床诊断为T1期肺腺癌且血清癌胚抗原正常并接受标准外科手术的患者。使用两种不同的CT成像设置评估肿瘤最大径:肺窗(lDmax)和纵隔窗(mDmax)。我们分析了预后或淋巴结受累与肿瘤大小之间的关系。
mDmax是淋巴结转移的显著预测因素(比值比1.11,P = 0.02)。然而,lDmax不显著(P = 0.83)。将年龄、性别、lDmax、mDmax和淋巴结受累作为预后的预测因素进行分析。在单因素分析中,mDmax和淋巴结受累是预后的显著预测因素(分别为比值比1.07,P = 0.01;比值比2.56,P = 0.04)。在多因素分析中,mDmax是预后的显著预测因素(比值比1.06,P = 0.04)。然后,我们根据mDmax将C-T1期腺癌患者分为三组:T1a(≤10 mm)、T1b(11至20 mm)和T1c(21至30 mm)。三组之间存在显著差异:5年无病生存率分别为93.3%、58.1%和32.7%(P = 0.01)。
mDmax可提供额外的有用预后数据。这一发现可能为肺腺癌的CT分类提供新的标准。